Sebastian Walsh, University of Cambridge
A prominent childhood memory is of my grandparents living with and then dying from dementia. As is universal with dementia, there was a double blow: watching my grandparents lose their identity and seeing the suffering of those closest to them.
The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer’s disease demonstrate an important advancement in Alzheimer’s research and treatment. The full Phase 3 data was reported at the Alzheimer’s Association International Conference® (AAIC®) 2023, in Amsterdam, Netherlands, and online. The data were simultaneously published in the Journal of the American Medical Association. Continue reading
NEW YORK, April 14, 2023 /Health/– Here are some of the top health news stories from this week:
New COVID-19 variant BA.2 spreads rapidly in Europe and the US
US Supreme Court to hear case on abortion rights
WHO reports more than 1 million deaths from COVID-19
New study finds that obesity can increase risk of dementia
Researchers develop new drug that could treat Alzheimer’s disease
Continue reading
Andrea Sturchio, Karolinska Institutet; Kariem Ezzat, Karolinska Institutet, and Samir EL Andaloussi, Karolinska Institutet
In 1906, Alois Alzheimer, a psychiatrist and neuroanatomist, reported “a peculiar severe disease process of the cerebral cortex” to a gathering of psychiatrists in Tübingen, Germany. The case was a 50-year-old woman who suffered from memory loss, delusions, hallucinations, aggression and confusion – all of which worsened until her untimely death five years later.